PubHawk
Rheum Dis Clin North Am May 2016 PMID 27133485

The History of Patient-Reported Outcomes in Rheumatology.

Leigh F Callahan

Full text PDF Download social card

Mentions

6
Peak: 5 in Dec 2021
across 2 sources since Dec 2021

Extended reach

3,178
potential audience

Total likes

12

Video views

36

Mentions per month

Dec 2021 – Feb 2022

Where it's discussed

  • X / Twitter5 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions are mostly brief mentions of conferences and hashtags related to the publication, such as references to the ACR21 congress, which suggests an awareness but limited engagement. The tone is neutral and informational, with no detailed analysis or personal insights, reflecting moderate interest and low-level impact overall.

AgreementNeither agree nor disagree

The brief posts mainly acknowledge the topic without expressing strong opinions, indicating neutrality or mild support.

InterestModerate interest

Comments show some interest in the subject, highlighted by mentions of conferences and hashtags, but lack depth.

EngagementNeutral engagement

The posts are relatively superficial, mostly sharing tags or titles without detailed discussion.

ImpactModerate impact

Given the minimal content, the overall influence on broader discourse seems modest, though they acknowledge relevant events.

Abstract in brief

  • The use of patient-reported outcomes (PROs) in rheumatology started in the early 1980s, helping to shift focus from just biomedical factors to a more comprehensive biopsychosocial approach to health.
  • Initially, PROs were mainly used in clinical trials and research, but recently they've become more common in everyday clinical care for rheumatology patients.
  • Over 250 reliable and valid PRO scales have been created to assess what matters most to patients with rheumatic diseases, and this measurement approach is continuously improving.]
Read the full abstract

Top posts

Most liked on X and Bluesky
Meed_reference
@meed_ref · X

#Distillates #PROs Patient-Reported Outcomes en el Congreso #ACR21

Dec 15, 2021 · 4 likes · 4 shares · 197 followers View post →
GRESSER
@GRESSER_Espa · X

RT @meed_ref: #Distillates #PROs Patient-Reported Outcomes en el Congreso #ACR21

Dec 15, 2021 · 4 shares · 1,651 followers View post →
J A Ca Vi
@JACV1968 · X

RT @meed_ref: #Distillates #PROs Patient-Reported Outcomes en el Congreso #ACR21

Feb 20, 2022 · 4 shares · 757 followers View post →
Rafael Lopez
@Rafa_Lop · X

RT @meed_ref: #Distillates #PROs Patient-Reported Outcomes en el Congreso #ACR21

Dec 15, 2021 · 4 shares · 428 followers View post →

All mentions

J A Ca Vi
@JACV1968 · X

RT @meed_ref: #Distillates #PROs Patient-Reported Outcomes en el Congreso #ACR21

Feb 20, 2022 · 4 shares · 757 followers View post →
GRESSER
@GRESSER_Espa · X

RT @meed_ref: #Distillates #PROs Patient-Reported Outcomes en el Congreso #ACR21

Dec 15, 2021 · 4 shares · 1,651 followers View post →
Pepitaflora
@veramarinofer · X

RT @meed_ref: #Distillates #PROs Patient-Reported Outcomes en el Congreso #ACR21

Dec 15, 2021 · 4 shares · 69 followers View post →
Rafael Lopez
@Rafa_Lop · X

RT @meed_ref: #Distillates #PROs Patient-Reported Outcomes en el Congreso #ACR21

Dec 15, 2021 · 4 shares · 428 followers View post →
Meed_reference
@meed_ref · X

#Distillates #PROs Patient-Reported Outcomes en el Congreso #ACR21

Dec 15, 2021 · 4 likes · 4 shares · 197 followers View post →